Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

BARBARA P EVANGELISTI

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1871700658
CMS profile
10845056
Location
BARTLETT, TN

General Payments · PY2023–2024

$532.20

  • Reported across 27 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$291.09

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $291.09 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $137.71 6
Ardelyx, Inc. $45.19 2
Boehringer Ingelheim Pharmaceuticals, Inc. $31.99 2
GlaxoSmithKline, LLC. $29.92 2
Amgen Inc. $17.21 1
Lilly USA, LLC $15.76 1
IDORSIA PHARMACEUTICALS US INC $13.31 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2023 $241.11 12
PY2024 $291.09 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $17.21 04/11/2024 Food and Beverage Undisputed 01/23/2026 1115608270 CMS
Ardelyx, Inc. $24.20 10/02/2024 Food and Beverage Undisputed 01/23/2026 1146725874 CMS
Ardelyx, Inc. $20.99 12/13/2024 Food and Beverage Undisputed 01/23/2026 1146725876 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $14.94 01/04/2024 Food and Beverage Undisputed 01/23/2026 1118204630 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.05 07/02/2024 Food and Beverage Undisputed 01/23/2026 1118204634 CMS
GlaxoSmithKline, LLC. $15.79 01/09/2024 Food and Beverage Undisputed 01/23/2026 1116628940 CMS
GlaxoSmithKline, LLC. $14.13 02/06/2024 Food and Beverage Undisputed 01/23/2026 1115949549 CMS
IDORSIA PHARMACEUTICALS US INC $13.31 10/18/2024 Food and Beverage Undisputed 01/23/2026 1146792146 CMS
Lilly USA, LLC $15.76 05/22/2024 Food and Beverage Undisputed 01/23/2026 1135574714 CMS
Novo Nordisk Inc $24.56 02/21/2024 Food and Beverage Undisputed 01/23/2026 1100317418 CMS
Novo Nordisk Inc $22.11 02/27/2024 Food and Beverage Undisputed 01/23/2026 1100331374 CMS
Novo Nordisk Inc $20.56 02/28/2024 Food and Beverage Undisputed 01/23/2026 1100655409 CMS
Novo Nordisk Inc $24.22 03/07/2024 Food and Beverage Undisputed 01/23/2026 1100618818 CMS
Novo Nordisk Inc $22.36 05/24/2024 Food and Beverage Undisputed 01/23/2026 1100332893 CMS
Novo Nordisk Inc $23.90 08/06/2024 Food and Beverage Undisputed 01/23/2026 1100410972 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2023, 2024
Source files
Dataset page · Bulk file · PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.